Cargando…

Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck

Squamous cell carcinoma of head and neck (SCCHN) is the most common neoplasm of the upper aerodigestive tract. In this paper, we attempt to summarize the role and applications of the epidermal growth factor receptor (EGFR) inhibitors monoclonal antibodies (moAbs) and tyrosine kinase inhibitors (TKIs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaib, Walid, Kono, Scott, Saba, Nabil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388373/ https://www.ncbi.nlm.nih.gov/pubmed/22778735 http://dx.doi.org/10.1155/2012/521215

Ejemplares similares

Update in Antiepidermal Growth Factor Receptor Therapy in the Management of Metastatic Colorectal Cancer
por: Loong, Herbert H., et al.
Publicado: (2009)

Antiepidermal Growth Factor Receptor Monoclonal Antibodies: Applications in Colorectal Cancer
por: Azizi, Efat, et al.
Publicado: (2012)

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab
por: Kono, Scott A., et al.
Publicado: (2012)

Targeted Antiepidermal Growth Factor Receptor (Cetuximab) Immunoliposomes Enhance Cellular Uptake In Vitro and Exhibit Increased Accumulation in an Intracranial Model of Glioblastoma Multiforme
por: Mortensen, Joachim Høg, et al.
Publicado: (2013)

Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor
por: Singh, Tripti, et al.
Publicado: (2015)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck
por: Russell, Jeffery S., et al.
Publicado: (2012)

Nerve Growth Factor (NGF)—Receptor Survival Axis in Head and Neck Squamous Cell Carcinoma
por: Dudás, József, et al.
Publicado: (2018)

Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation
por: Koch, Dominik Thomas, et al.
Publicado: (2017)

Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Patel, Bhamini, et al.
Publicado: (2021)

Commentary: Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)
por: Saba, Nabil F.
Publicado: (2017)

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
por: Saba, Nabil F., et al.
Publicado: (2022)

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
por: Ho, Alan L., et al.
Publicado: (2021)

Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.
por: Stanton, P., et al.
Publicado: (1994)

Aberrant Methylation Inactivates Transforming Growth Factor β Receptor I in Head and Neck Squamous Cell Carcinoma
por: Muñoz-Antonia, Teresita, et al.
Publicado: (2009)

Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck
por: Iberri, David J., et al.
Publicado: (2016)

Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma
por: Farnebo, Lovisa, et al.
Publicado: (2015)

The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma
por: Hamoir, Marc, et al.
Publicado: (2018)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status
por: Hofman, P, et al.
Publicado: (2008)

Meta-analysis of the effects of anti-epidermal growth factor receptor on recurrent/metastatic head and neck squamous cell carcinoma
por: Xin, Yong, et al.
Publicado: (2018)

Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival
por: Novin, Kambiz, et al.
Publicado: (2015)

The prospects and challenges of chimeric antigen receptor T cell therapy for head and neck squamous cell carcinoma
por: Liu, Wei, et al.
Publicado: (2023)

Therapeutic implication of chimeric antigen receptor T-cell therapy for head and neck squamous cell carcinoma
por: Pazhani, Jayanthi, et al.
Publicado: (2023)

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
por: Reuter, C W M, et al.
Publicado: (2007)

Review of Outcomes after Salvage Surgery for Recurrent Squamous Cell Carcinoma of the Head and Neck
por: Hartl, Dana M., et al.
Publicado: (2023)

The Future Prospects of Immune Therapy in Gastric and Esophageal Adenocarcinoma
por: Shaib, Walid L., et al.
Publicado: (2016)

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
por: Mineta, H, et al.
Publicado: (2000)

Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells
por: Dawson, John C., et al.
Publicado: (2011)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2022)

Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck
por: Bauernhofer, T, et al.
Publicado: (2011)

Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review
por: Ipenburg, Norbertus A., et al.
Publicado: (2015)

Evaluation of Methylation Profiles of An Epidermal Growth Factor Receptor Gene in a Head and Neck Squamous Cell Carcinoma Patient Group
por: Mutlu, M, et al.
Publicado: (2021)

Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma
por: Oosting, Sjoukje F., et al.
Publicado: (2019)

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
por: Kordbacheh, Farzaneh, et al.
Publicado: (2021)

Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma
por: Wang, Han-Qi, et al.
Publicado: (2023)

Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Zheng, Shuwen, et al.
Publicado: (2023)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6t8s4n73uaogpu3gn16iaacius